Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways
K Huynh, BC Bernardo, JR McMullen… - Pharmacology & …, 2014 - Elsevier
Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic
population. Both experimental and clinical evidence suggest that diabetic subjects are …
population. Both experimental and clinical evidence suggest that diabetic subjects are …
Microvolt T-wave alternans: physiological basis, methods of measurement, and clinical utility—consensus guideline by International Society for Holter and …
RL Verrier, T Klingenheben, M Malik, N El-Sherif… - Journal of the American …, 2011 - jacc.org
This consensus guideline was prepared on behalf of the International Society for Holter and
Noninvasive Electrocardiology and is cosponsored by the Japanese Circulation Society, the …
Noninvasive Electrocardiology and is cosponsored by the Japanese Circulation Society, the …
Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in-congestive heart failure (MERIT-HF)
Merit-HF Study Group - The Lancet, 1999 - Elsevier
BACKGROUND: Metoprolol can improve haemodynamics in chronic heart failure, but
survival benefit has not been proven. We investigated whether metoprolol controlled …
survival benefit has not been proven. We investigated whether metoprolol controlled …
Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications
MK Lahiri, PJ Kannankeril, JJ Goldberger - Journal of the American college …, 2008 - jacc.org
Certain abnormalities of autonomic function in the setting of structural cardiovascular
disease have been associated with an adverse prognosis. Various markers of autonomic …
disease have been associated with an adverse prognosis. Various markers of autonomic …
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
Cardiovascular (CV) disease is the leading cause of morbidity and mortality in both sexes in
developed countries, but gender differences exists in its diagnosis and treatment. Since the …
developed countries, but gender differences exists in its diagnosis and treatment. Since the …
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
N Jochmann, K Stangl, E Garbe… - European heart …, 2005 - academic.oup.com
Differences in pharmacokinetics, pharmacodynamics, and physiology contribute to the
phenomenon that women and men frequently respond differently to cardiovascular drugs …
phenomenon that women and men frequently respond differently to cardiovascular drugs …
Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials
F Burzotta, M De Vita, YL Gu, T Isshiki… - European heart …, 2009 - academic.oup.com
Aims Thrombectomy in patients with ST-elevation myocardial infarction (STEMI) undergoing
percutaneous coronary intervention (PCI) is associated to better myocardial reperfusion …
percutaneous coronary intervention (PCI) is associated to better myocardial reperfusion …
Are changes in heart rate variability in middle‐aged and older people normative or caused by pathological conditions? Findings from a large population‐based …
VK Jandackova, S Scholes, A Britton… - Journal of the American …, 2016 - Am Heart Assoc
Background No study to date has investigated longitudinal trajectories of cardiac autonomic
modulation changes with aging; therefore, we lack evidence showing whether these …
modulation changes with aging; therefore, we lack evidence showing whether these …
Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: a systematic review and meta-analysis of cardio …
AK Singh, R Singh - Diabetes & Metabolic Syndrome: Clinical Research & …, 2020 - Elsevier
Background and aims Type 2 diabetes confers a differential risk of cardiovascular (CV)
disease according to the gender. Whether newly approved anti-diabetic drugs like sodium …
disease according to the gender. Whether newly approved anti-diabetic drugs like sodium …
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study
V Kühlkamp, A Schirdewan, K Stangl… - Journal of the American …, 2000 - jacc.org
OBJECTIVES The primary objective of the present study was to assess the efficacy of
metoprolol CR/XL to reduce the risk of relapse after cardioversion of persistent atrial …
metoprolol CR/XL to reduce the risk of relapse after cardioversion of persistent atrial …